Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
Hovione announced that it has expanded its continuous manufacturing offering and services. A new continuous manufacturing facility is now coming online at the Loures site in Portugal.
read more
The vegan supplement market will grow by $3.43B by 2026, with a 37% increase in Europe, according to a report by Technavio.
read more
The global pharmaceutical coating equipment market size is anticipated to reach $1.27B by 2030, according to a new report by Grand View Research, expanding at a CAGR of 5.2% from 2022 to 2030.
read more
Novo Nordisk has agreed to buy Forma Therapeutics for $1.1B to expand its blood disorders portfolio.
read more
Amneal Pharmaceuticals announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for IPX203, a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules for the treatment of Parkinson’s disease (PD).
read more
Cambrex announced the completion of the first phase of its $30M investment in its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. T
read more
Vaxart reported positive top-line data from the first part of a planned two-part Phase II study of its Wuhan S-only oral pill COVID-19 vaccine candidate, VXA-CoV2-1.1-S.
read more
Recordati Rare Diseases announces the publication of the long-term outcomes from the open-label extension period of the Phase III LINC 3 study of ISTURISA in The European Journal of Endocrinology.
read more
The FDA has accepted Sanofi and Sobi’s Biologics License Application (BLA) for hemophilia drug efanesoctocog alpha, granting the drug priority review status. The target action date for the FDA decision is February 28, 2023.
read more
JAMP Pharma Corporation is voluntarily recalling one product lot of Atorvastatin tablets, 40 mg, 100-format (lot D10776B) at the retail level (type 1 recall).
read more
The anticoagulants market value is projected to exceed $80B by 2030, according to a report by Global Market Insights Inc.
read more
Lysulin, a blood sugar supplement, is now available in the U.S.
Clinical studies show Lysine and Vitamin C help maintain healthy blood sugar levels, according to the company. Millions of people have excess sugar in their bloodstream, which can have adverse effects on the body's organs.
read more
ANI Pharmaceuticals announced the launch of Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg.
read more
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
read more
The global active pharmaceutical ingredients (API) market size reached$209.9B in 2021, according to a report from Research & markets. Looking forward, the publisher expects the market to reach$291.7B by 2027, exhibiting a CAGR of 5.64% during 2021-2027.
read more